Paydirt
MH
Insider

Mark W Hahn

Chief Financial Officer

Mark W Hahn (Chief Financial Officer) filed 10 Form 4 reports in the past 24 months (0 purchases, 10 sales), most often in VRNA. The largest single filing was $5.3M of VRNA (587,008 sh across 3 lots, as filed), executed May 1 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
10
0 buys · 10 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$25.6M
shares × price, as filed
Last traded
Aug 1 2025
Filed Aug 5 2025
Open performance→
Volume by month
$9.9M$4.9M$0Oct 2024Apr 2025Oct 2025Apr 2026Oct 2024 · sells $2.9MNov 2024 · sells $569KDec 2024 · sells $4.9MMay 2025 · sells $9.9MJun 2025 · sells $4.6MAug 2025 · sells $2.7M
Buys $0 Sells $25.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Not on file 10 filings

Sector per market data · by filing · past 24 months

Most traded names
VRNA VRNA VRNA · 0 buys · 10 sells 10 filings
Recent filings
VRNASALE Verona Pharma plc View filing → $619K
141,360 sh × $4.38
Exec Oct 24 2024
Filed Oct 25 2024 · 5:30 PM ET VRNASALE Verona Pharma plc View filing → $2.3M
525,768 sh across 3 lots
Exec Oct 18 2024
Filed Oct 22 2024 · 5:30 PM ET VRNASALE Verona Pharma plc View filing → $2.3M
600,000 sh × $3.76
Exec Sep 11 2024
Filed Sep 13 2024 · 5:30 PM ET